Pharmacy-based PrEP for Young Women Who Sell Sex in Zimbabwe
Launched by UNIVERSITY OF CALIFORNIA, BERKELEY · Mar 29, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called “Pharmacy-based PrEP for Young Women Who Sell Sex in Zimbabwe,” is exploring a new way to help young women who sell sex protect themselves from HIV. The study aims to make it easier for these women to access a preventive medication known as PrEP, which can significantly reduce the risk of getting HIV. Currently, many women who start taking PrEP stop returning for their medication after just a few months. By providing PrEP through pharmacies and offering small rewards, like gift cards, the researchers hope to encourage more women to keep using the medication consistently.
To participate in this trial, individuals must be at least 16 years old, have sold sex for money or gifts in the last six months, and be HIV negative at the time of enrollment. Participants can expect support and guidance throughout the study, as well as a chance to contribute to important research that could improve HIV prevention for women in similar situations. This trial is currently recruiting participants, so it’s a great opportunity for those eligible to take part in a meaningful cause.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1) Exchanged sexual intercourse for money or gifts in past 6 months
- • 2) Age 16 or older
- • 3) HIV negative (via rapid test per national guidelines) at enrollment and no signs/symptoms of acute HIV infection
About University Of California, Berkeley
The University of California, Berkeley, a leading research institution renowned for its commitment to scientific innovation and academic excellence, serves as a prominent sponsor of clinical trials aimed at advancing medical knowledge and improving patient outcomes. With a robust infrastructure for interdisciplinary collaboration, UC Berkeley leverages its distinguished faculty, cutting-edge laboratories, and extensive resources to conduct research that addresses critical health challenges. The university is dedicated to fostering a culture of ethical research practices and ensuring the highest standards of safety and efficacy in its clinical investigations, ultimately contributing to the translation of scientific discoveries into tangible health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Harare, , Zimbabwe
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported